CompletedNot Applicable

Evaluation of a Decision Aid Tool in Rectal Cancer patiënts

Belgium70 participantsStarted 2022-04-22

Plain-language summary

Adapt and evaluate a decision aid for patients with rectal cancer. Phase 1 : decision aid testing (Delphi) multicentric Phase 2: pilot test decision aid

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Delphi procedure Inclusion Criteria: * expert healthcare professionals caring for patients with rectal cancer Exclusion Criteria: * none Interviews Inclusion criteria * Patients in which the decision aid was tested * patients with a tumor in the last 10cm of the rectum * healthcare professionals who have used the decision aid tool * informal carer indicated by the patient Exclusion * patients who have no treatment choice due to oncological reasons

What they're measuring

Assessment of accuracy of the decision aid tool trough a delphi procedure

Timeframe: 2-3 months (until consensus)

Assessment of clarity of the decision aid tool trough a delphi procedure

Timeframe: 2-3 months (until consensus)

Assessment of relevance of the decision aid tool trough a delphi procedure

Timeframe: 2-3 months (until consensus)

Assessment of readability of the decision aid tool trough a delphi procedure

Timeframe: 2-3 months (until consensus)

Assessment of the acceptability of the decision aid tool through individual interview

Timeframe: about 60 minutes

Assessment of the usability of the decision aid tool through individual interviews

Timeframe: about 60 minutes

Trial details

NCT IDNCT04938336

SponsorUniversity Hospital, Ghent

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-07-10

View on ClinicalTrials.gov More Low Anterior Resection Syndrome trials